Eli Lilly and Company is pouring $5 billion into a new manufacturing hub in Goochland County, Virginia, a move that ramps up the drugmaker’s footprint in the United States at a time when global supply chains face mounting pressures. The facility at West Creek Business Park will focus on producing active pharmaceutical ingredients essential for treatments targeting cancer, autoimmune diseases, and other complex conditions.
This project builds on an earlier blueprint for a $2.1 billion site and stands as part of Eli Lilly’s broader strategy to invest heavily in domestic operations, with the company eyeing at least $27 billion across four new U.S. plants announced earlier this year.
The scale of this commitment reflects a calculated response to evolving trade dynamics, including President Trump’s outlined tariffs on imported pharmaceuticals. Trump has proposed starting with modest duties before escalating them—potentially to 150% within a year or so, and up to 250% thereafter—to compel the industry toward homegrown manufacturing. Such measures aim to fortify national security in medicine production, reducing reliance on overseas suppliers vulnerable to disruptions. Eli Lilly’s Virginia expansion arrives just as these policies take shape, demonstrating how targeted incentives can draw major capital back to American soil.
Lilly CEO David Ricks framed the investment as a direct bet on the nation’s future.
“Our investment in Virginia underscores our commitment to U.S. innovation and manufacturing – creating high-quality jobs, strengthening communities, and advancing the health and well-being of Americans nationwide,” Ricks said.
The plant promises 650 permanent positions for engineers, scientists, operators, and lab technicians—roles that pay well above local averages and anchor families in the region.
Ricks continued, “By expanding our domestic capacity, we’re building a secure, resilient supply chain that delivers for patients today and supports the breakthrough medicines of tomorrow.”
In practical terms, that means faster access to therapies like those for diabetes and obesity, where Eli Lilly has led with blockbusters such as Mounjaro and Zepbound. A fortified supply chain could shave weeks or months off delivery times, a boon for patients who can’t afford delays.
Virginia Governor Glenn Youngkin hailed the development as a win for the commonwealth and the country alike.
“Lilly is one of the world’s greatest innovators, and I want to thank them for this significant commitment to Virginia,” Youngkin stated in an official release.
The governor’s enthusiasm points to the ripple effects: beyond the 650 direct hires, the project will generate 1,800 construction jobs during its buildout, injecting vitality into Goochland’s economy.
Youngkin added, “By expanding manufacturing capacity here in the United States, we are strengthening our economy, securing America’s critical pharmaceutical supply chain, and positioning Virginia to lead in the industries that will drive innovation for generations to come.”
This aligns with Virginia’s track record of luring biotech firms, from AstraZeneca’s expansions in the state to emerging clusters in Richmond. The governor’s office estimates the facility could contribute hundreds of millions in annual economic output once operational, fostering a cycle of growth that benefits suppliers, schools, and small businesses nearby.
Eli Lilly isn’t alone in this shift. Johnson & Johnson recently pledged $2 billion for U.S. manufacturing upgrades, creating hundreds of jobs in states like Pennsylvania and North Carolina. These announcements echo a pattern: as tariffs loom, pharma leaders are redirecting funds stateside to sidestep risks and tap into a skilled workforce. Trump’s approach, while drawing fire from some quarters over potential short-term price hikes, prioritizes long-term self-sufficiency—a priority that resonates in Rust Belt towns and Southern hubs alike, where factory revivals mean real paychecks.
For Goochland County, a rural pocket west of Richmond with a population under 25,000, the Lilly plant arrives as a transformative force. Local leaders anticipate it will spur infrastructure improvements and housing demand, easing the commute for workers from nearby Henrico and Chesterfield counties. As one Virginia economic development official put it in a recent briefing, this isn’t just about pills—it’s about planting seeds for a biotech corridor that could rival Boston’s or San Francisco’s in scale.
In the end, Eli Lilly’s $5 billion stake in Virginia underscores a pivotal moment for American industry: the pivot from offshoring to onshoring, driven by policy and pragmatism. With breakthroughs in gene therapies and personalized medicine on the horizon, facilities like this one will be the backbone of delivering them affordably and reliably to U.S. patients. As Ricks and Youngkin both emphasize, the gains extend far beyond the factory floor—to healthier communities and a more robust economy.
Bypass Big Tech Censors
For Emergency Preparedness, Don’t Forget the Meds
Being prepared is more than just a good idea—it’s essential. We stock up on non-perishable food, bottled water, flashlights, and first-aid supplies, but one critical aspect often gets overlooked: access to vital medications. What happens if pharmacies close, prescriptions can’t be filled, or you’re cut off from medical care during an emergency?
That’s where Jase Medical steps in, offering a reliable solution to ensure you and your family have the medications you need when it matters most.
Jase Medical specializes in emergency preparedness kits designed to provide peace of mind through physician-reviewed, prescription medications delivered right to your door. Their flagship product, the Jase Case, is a comprehensive emergency antibiotic and medication kit priced at $289.95.
This kit includes 10 essential medications—five life-saving antibiotics and five symptom relief meds—that can treat over 50 common infections and illnesses, from urinary tract infections and pneumonia to skin infections and traveler’s diarrhea. With 28 add-on options available, you can customize the kit to fit your specific needs, including a KidCase for children ages 2-11.
The process is straightforward and hassle-free. Simply visit Patriot.tv/meds, complete an online evaluation, and have your order reviewed by a board-certified physician. Once approved, the medications are shipped discreetly from a licensed pharmacy to your U.S. address (with plans for Canada shipping coming soon). Each kit comes with detailed Med Cards outlining symptoms, dosing, and usage, making it easy to administer even in high-stress situations. These medications are shelf-stable and designed for long-term storage, empowering you to handle medical emergencies without relying on external help.
For those on the move, Jase Medical also offers the Jase Go kit for $129.95, a compact travel med kit covering over 30 common conditions encountered during adventures or trips. And for ongoing needs, Jase Daily provides an extended supply of your prescribed chronic medications to safeguard against disruptions in supply chains or extreme weather events.
Don’t just take our word for it—thousands of satisfied customers have given Jase Medical a 4.9-star rating, praising its role in true preparedness. As radio host Glenn Beck warns, “The supply lines for antibiotics already are stressed to the max. Please have some antibiotics on hand… You can do it through Jase.”
Whether you’re prepping for a hurricane, a power outage, or simply the uncertainties of daily life, Jase Medical ensures you’re not caught off guard. Head to patriot.tv/meds today to customize and order your emergency kit—because when it comes to your health and safety, it’s better to be prepared than sorry.
